Puma Biotechnology (PBYI) Interest Expenses (2011 - 2026)

Puma Biotechnology's Interest Expenses history runs 16 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• Quarterly Interest Expenses fell 56.77% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 56.77% YoY) and the FY2025 annual result came in at $9.7 million, down 97.18% from the prior year.
• Interest Expenses was $4.2 million for Q1 2026 at Puma Biotechnology, up from $1.7 million in the prior quarter.
• Across five years, Interest Expenses topped out at $10.4 million in Q2 2024 and bottomed at -$6.8 million in Q4 2022.
• A 5-year average of $6.6 million and a median of $8.0 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses sank 159.21% — and 2025, when it jumped 453.65%.
• Puma Biotechnology's Interest Expenses stood at -$6.8 million in 2022, then jumped by 167.65% to $4.6 million in 2023, then declined by 13.89% to $4.0 million in 2024, then sank by 58.28% to $1.7 million in 2025, then surged by 153.2% to $4.2 million in 2026.
• Business Quant data shows PBYI's Interest Expenses at $4.2 million in Q1 2026, $1.7 million in Q4 2025, and $9.7 million in Q3 2025.